|
G |
GSTP1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
cobamamide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases expression multiple interactions |
EXP |
Vitamin B 12 results in decreased expression of ABCB1 mRNA; Vitamin B 12 results in decreased expression of ABCB1 protein Vitamin B 12 inhibits the reaction [Methotrexate results in increased expression of ABCB1 mRNA] |
CTD |
PMID:17982279 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ABCC4 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCD4 |
ATP binding cassette subfamily D member 4 |
affects metabolic processing |
EXP |
ABCD4 protein affects the metabolism of Vitamin B 12 |
CTD |
PMID:22922874 |
|
NCBI chr14:74,285,269...74,302,934
Ensembl chr14:74,285,269...74,303,055
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
[Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACACA mRNA |
CTD |
PMID:22648174 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACACB |
acetyl-CoA carboxylase beta |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of ACACB mRNA |
CTD |
PMID:33549593 |
|
NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA] |
CTD |
PMID:18239293 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
ADGRG2 |
adhesion G protein-coupled receptor G2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ADGRG2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr X:18,989,307...19,122,956
Ensembl chr X:18,989,307...19,122,637
|
|
G |
AKR1B15 |
aldo-keto reductase family 1 member B15 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of AKR1B7 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
multiple interactions |
ISO |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate co-treated with Ethanol] results in increased expression of ALDH2 protein |
CTD |
PMID:20118189 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
G |
AS3MT |
arsenite methyltransferase |
multiple interactions |
EXP |
Folic Acid promotes the reaction [Vitamin B 12 promotes the reaction [AS3MT protein results in increased methylation of Arsenic]]; Vitamin B 12 promotes the reaction [AS3MT protein results in increased methylation of Arsenic] |
CTD |
PMID:20049124 |
|
NCBI chr10:102,869,470...102,901,899
Ensembl chr10:102,869,470...102,901,899
|
|
G |
AXIN1 |
axin 1 |
multiple interactions |
ISO |
[Folic Acid co-treated with Vitamin B 12 co-treated with Betaine co-treated with Choline] results in increased methylation of AXIN1 gene |
CTD |
PMID:16868943 |
|
NCBI chr16:287,440...352,723
Ensembl chr16:287,440...352,723
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of BDNF protein] |
CTD |
PMID:38049026 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
Folic Acid inhibits the reaction [Vitamin B 12 promotes the reaction [Dietary Fats results in increased expression of CASP3 mRNA]]; Vitamin B 12 inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; Vitamin B 12 promotes the reaction [Dietary Fats results in increased expression of CASP3 mRNA] |
CTD |
PMID:23935743 PMID:38049026 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
multiple interactions |
ISO |
Folic Acid inhibits the reaction [Vitamin B 12 promotes the reaction [Dietary Fats results in increased expression of CASP8 mRNA]]; Vitamin B 12 promotes the reaction [Dietary Fats results in increased expression of CASP8 mRNA] |
CTD |
PMID:23935743 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate co-treated with Ethanol] results in increased activity of CAT protein Vitamin B 12 promotes the reaction [Folic Acid inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein]] |
CTD |
PMID:16214333 PMID:20118189 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBS |
cystathionine beta-synthase |
multiple interactions |
ISO |
[Fatty Acids, Omega-3 co-treated with Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of CBS mRNA; [Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in increased expression of CBS mRNA; [Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of CBS mRNA |
CTD |
PMID:25003120 |
|
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA |
CTD |
PMID:22648174 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CD40 |
CD40 molecule |
multiple interactions |
EXP |
[Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in decreased expression of CD40 mRNA |
CTD |
PMID:30116142 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CDK1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CLCF1 |
cardiotrophin like cytokine factor 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CLCF1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr11:67,364,168...67,374,177
Ensembl chr11:67,364,168...67,374,177
|
|
G |
CRP |
C-reactive protein |
multiple interactions |
EXP |
[Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein |
CTD |
PMID:16517955 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CYP26A1 |
cytochrome P450 family 26 subfamily A member 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr10:93,073,475...93,077,885
Ensembl chr10:93,073,475...93,077,885
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions |
ISO |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] |
CTD |
PMID:20118189 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions |
ISO EXP |
Vitamin B 12 inhibits the reaction [Streptozocin results in increased expression of DDIT3 protein] [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of DDIT3 protein] |
CTD |
PMID:37263574 PMID:38049026 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DEPP1 |
DEPP autophagy regulator 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of DEPP1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
|
|
G |
E2F8 |
E2F transcription factor 8 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGFR mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of EGR1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:38049026 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
ESCO2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640
|
|
G |
FABP5 |
fatty acid binding protein 5 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
|
|
G |
FADS1 |
fatty acid desaturase 1 |
multiple interactions |
ISO |
[Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in decreased expression of FADS1 mRNA; [Folic Acid co-treated with Vitamin B 12 deficiency] results in decreased expression of FADS1 mRNA; [Vitamin B 12 deficiency co-treated with Fatty Acids, Omega-3] results in decreased activity of FADS1 protein; Folic Acid inhibits the reaction [[Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in decreased expression of FADS1 mRNA]; Folic Acid promotes the reaction [[Vitamin B 12 deficiency co-treated with Fatty Acids, Omega-3] results in decreased activity of FADS1 protein]; Vitamin B 12 deficiency promotes the reaction [Folic Acid results in increased activity of FADS1 protein] |
CTD |
PMID:22133376 |
|
NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
|
|
G |
FADS2 |
fatty acid desaturase 2 |
multiple interactions |
ISO |
[Vitamin B 12 deficiency co-treated with Fatty Acids, Omega-3] results in decreased activity of FADS2 protein; [Vitamin B 12 deficiency co-treated with Folic Acid] results in decreased activity of FADS2 protein; Folic Acid inhibits the reaction [[Vitamin B 12 deficiency co-treated with Fatty Acids, Omega-3] results in decreased activity of FADS2 protein] |
CTD |
PMID:22133376 |
|
NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354
|
|
G |
FASN |
fatty acid synthase |
multiple interactions |
ISO |
[Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid] affects the reaction [[Dietary Fats co-treated with Dietary Sucrose] affects the methylation of FASN promoter] |
CTD |
PMID:22648174 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FOLH1 |
folate hydrolase 1 |
multiple interactions |
EXP |
Vitamin B 12 affects the reaction [FOLH1 gene SNP affects the susceptibility to and affects the metabolism of Arsenic] |
CTD |
PMID:29459232 |
|
NCBI chr11:49,145,092...49,208,602
Ensembl chr11:49,145,092...49,208,638
|
|
G |
FUT2 |
fucosyltransferase 2 (H blood group) |
affects abundance |
EXP |
FUT2 gene polymorphism affects the abundance of Vitamin B 12 |
CTD |
PMID:18776911 |
|
NCBI chr19:48,695,971...48,705,951
Ensembl chr19:48,695,971...48,705,951
|
|
G |
GADD45B |
growth arrest and DNA damage inducible beta |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GADD45B mRNA |
CTD |
PMID:33549593 |
|
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805
|
|
G |
GADD45G |
growth arrest and DNA damage inducible gamma |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
|
|
G |
GCK |
glucokinase |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GCK mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of GDNF protein] |
CTD |
PMID:38049026 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GFAP |
glial fibrillary acidic protein |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in increased expression of GFAP protein] |
CTD |
PMID:38049026 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GNA14 |
G protein subunit alpha 14 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GNA14 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 9:77,423,079...77,648,322
Ensembl chr 9:77,423,079...77,648,322
|
|
G |
GPCPD1 |
glycerophosphocholine phosphodiesterase 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GPCPD1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr20:5,544,439...5,611,006
Ensembl chr20:5,544,404...5,611,006
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTA5 mRNA; [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of GSTA5 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
GSTM3 |
glutathione S-transferase mu 3 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
|
|
G |
GUCY1A1 |
guanylate cyclase 1 soluble subunit alpha 1 |
multiple interactions |
EXP |
3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine promotes the reaction [Vitamin B 12 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Vitamin B 12 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:22171090 |
|
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
|
|
G |
GUCY1B1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions |
EXP |
3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine promotes the reaction [Vitamin B 12 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]; Vitamin B 12 results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:22171090 |
|
NCBI chr 4:155,759,021...155,807,811
Ensembl chr 4:155,758,992...155,807,811
|
|
G |
HAVCR1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO EXP |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of HAVCR1 protein] |
CTD |
PMID:37263574 |
|
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
|
|
G |
HBA1 |
hemoglobin subunit alpha 1 |
affects expression affects glycosylation |
EXP |
Vitamin B 12 affects the expression of HBA1 protein modified form Vitamin B 12 affects the glycosylation of HBA1 protein |
CTD |
PMID:2299304 |
|
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of HMOX1 protein] |
CTD |
PMID:37263574 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP ISO |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of HSPA5 protein] Vitamin B 12 inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein] |
CTD |
PMID:37263574 PMID:38049026 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IL1B |
interleukin 1 beta |
increases methylation multiple interactions |
EXP |
Vitamin B 12 results in increased methylation of IL1B gene [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in decreased expression of IL1B mRNA; [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in decreased secretion of IL1B protein; [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased methylation of IL1B gene |
CTD |
PMID:30116142 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [arsenic trioxide results in increased expression of IL6 protein] |
CTD |
PMID:16214333 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IRS2 |
insulin receptor substrate 2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of IRS2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr13:109,752,695...109,786,583
Ensembl chr13:109,752,695...109,786,583
|
|
G |
ITGA8 |
integrin subunit alpha 8 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of ITGA8 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,922
|
|
G |
ITGB4 |
integrin subunit beta 4 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of ITGB4 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
|
|
G |
KRT4 |
keratin 4 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of KRT4 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr12:52,806,549...52,814,116
Ensembl chr12:52,806,549...52,814,116
|
|
G |
KYNU |
kynureninase |
multiple interactions |
ISO |
[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Rotenone results in decreased expression of KYNU mRNA] |
CTD |
PMID:36553663 |
|
NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,657...143,055,833
|
|
G |
LEPR |
leptin receptor |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of LEPR mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
LRATD1 |
LRAT domain containing 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRATD1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 2:14,632,717...14,651,916
Ensembl chr 2:14,632,700...14,650,814
|
|
G |
LRRC24 |
leucine rich repeat containing 24 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of LRRC24 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 8:144,522,388...144,527,033
Ensembl chr 8:144,522,388...144,527,033
|
|
G |
MAOB |
monoamine oxidase B |
decreases activity |
EXP |
Vitamin B 12 results in decreased activity of MAOB protein |
CTD |
PMID:7430361 |
|
NCBI chr X:43,766,610...43,882,450
Ensembl chr X:43,766,610...43,882,450
|
|
G |
MAP2 |
microtubule associated protein 2 |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] |
CTD |
PMID:38049026 |
|
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
|
|
G |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr19:38,587,641...38,617,953
Ensembl chr19:38,587,641...38,618,882
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Vitamin B 12 inhibits the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:14566972 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAT2A |
methionine adenosyltransferase 2A |
multiple interactions |
ISO |
[Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in increased expression of MAT2A mRNA; [Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of MAT2A mRNA; Fatty Acids, Omega-3 promotes the reaction [[Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of MAT2A mRNA] |
CTD |
PMID:25003120 |
|
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
|
|
G |
MBP |
myelin basic protein |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of MBP protein] |
CTD |
PMID:38049026 |
|
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
|
|
G |
MCM5 |
minichromosome maintenance complex component 5 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MCM5 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
|
|
G |
MCM6 |
minichromosome maintenance complex component 6 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MCM6 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
|
|
G |
MICAL1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MICAL1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 6:109,444,062...109,465,968
Ensembl chr 6:109,444,062...109,465,968
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MMACHC |
metabolism of cobalamin associated C |
increases metabolic processing affects binding decreases metabolic processing |
EXP |
MMACHC protein results in increased metabolism of Vitamin B 12 Vitamin B 12 analog binds to MMACHC protein; Vitamin B 12 binds to MMACHC protein MMACHC protein mutant form results in decreased metabolism of Vitamin B 12 |
CTD |
PMID:19700356 |
|
NCBI chr 1:45,500,300...45,513,382
Ensembl chr 1:45,500,300...45,513,382
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
decreases expression multiple interactions |
ISO |
Vitamin B 12 deficiency results in decreased expression of MTHFR mRNA [Folic Acid co-treated with Vitamin B 12 deficiency] results in decreased expression of MTHFR mRNA; Fatty Acids, Omega-3 inhibits the reaction [Vitamin B 12 deficiency results in decreased expression of MTHFR mRNA] |
CTD |
PMID:25003120 |
|
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
|
|
G |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects binding multiple interactions increases activity |
EXP ISO |
Vitamin B 12 binds to MTR protein [Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in decreased expression of MTR mRNA; Fatty Acids, Omega-3 promotes the reaction [Vitamin B 12 deficiency inhibits the reaction [Fatty Acids, Omega-3 results in increased expression of MTR mRNA]]; Vitamin B 12 deficiency inhibits the reaction [Fatty Acids, Omega-3 results in increased expression of MTR mRNA] Vitamin B 12 results in increased activity of MTR protein |
CTD |
PMID:17477549 PMID:17982279 PMID:25003120 |
|
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
|
|
G |
MYCL |
MYCL proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MYCL mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 1:39,895,428...39,901,917
Ensembl chr 1:39,895,428...39,902,256
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of NCF1 protein] |
CTD |
PMID:37263574 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO EXP |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of NFE2L2 protein] |
CTD |
PMID:37263574 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of NGF protein] |
CTD |
PMID:38049026 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NLRP12 |
NLR family pyrin domain containing 12 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of NLRP12 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr19:53,793,584...53,824,403
Ensembl chr19:53,792,139...53,824,403
|
|
G |
NPY |
neuropeptide Y |
multiple interactions |
ISO |
Vitamin B 12 affects the reaction [bisphenol A affects the expression of NPY mRNA] |
CTD |
PMID:32960947 |
|
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO EXP |
[Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of NQO1 protein] |
CTD |
PMID:37263574 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PEMT |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
ISO |
[Fatty Acids, Omega-3 co-treated with Vitamin B 12 deficiency] results in increased expression of PEMT mRNA; [Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of PEMT mRNA; Fatty Acids, Omega-3 inhibits the reaction [[Folic Acid co-treated with Vitamin B 12 deficiency] results in increased expression of PEMT mRNA] |
CTD |
PMID:25003120 |
|
NCBI chr17:17,505,563...17,592,142
Ensembl chr17:17,505,563...17,591,708
|
|
G |
PER2 |
period circadian regulator 2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of PER2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate co-treated with Ethanol] results in increased expression of PPARA protein |
CTD |
PMID:20118189 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]; Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] |
CTD |
PMID:23935743 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPP1R3G |
protein phosphatase 1 regulatory subunit 3G |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of PPP1R3G mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 6:5,085,341...5,089,487
Ensembl chr 6:5,085,341...5,089,487
|
|
G |
PRSS8 |
serine protease 8 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of PRSS8 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727
|
|
G |
RFX4 |
regulatory factor X4 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of RFX4 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr12:106,583,004...106,762,803
Ensembl chr12:106,583,004...106,762,803
|
|
G |
RGS16 |
regulator of G protein signaling 16 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of RGS16 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of RRM2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
|
|
G |
S100A8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of S100A8 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions increases methylation |
EXP |
[Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SERPINE1 mRNA; [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased methylation of SERPINE1 gene Vitamin B 12 results in increased methylation of SERPINE1 gene |
CTD |
PMID:30116142 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SERPINH1 |
serpin family H member 1 |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Dimethylnitrosamine results in increased expression of SERPINH1 mRNA] |
CTD |
PMID:18239293 |
|
NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783
|
|
G |
SLC25A30 |
solute carrier family 25 member 30 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455
|
|
G |
SOCS2 |
suppressor of cytokine signaling 2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
|
|
G |
SULT1E1 |
sulfotransferase family 1E member 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of SULT1E1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
|
|
G |
SYP |
synaptophysin |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of SYP protein] |
CTD |
PMID:38049026 |
|
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
|
|
G |
TCN2 |
transcobalamin 2 |
multiple interactions |
EXP |
TCN2 protein binds to and results in increased uptake of Vitamin B 12 |
CTD |
PMID:14632784 |
|
NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
Vitamin B 12 inhibits the reaction [Streptozocin results in decreased expression of TH protein] |
CTD |
PMID:38049026 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
[Folic Acid co-treated with Vitamin B 12] inhibits the reaction [arsenic trioxide results in increased expression of TNF protein] [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in decreased expression of TNF mRNA; [Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in decreased secretion of TNF protein |
CTD |
PMID:16214333 PMID:30116142 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
ULK1 |
unc-51 like autophagy activating kinase 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of ULK1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr12:131,894,622...131,923,150
Ensembl chr12:131,894,622...131,923,150
|
|
G |
USP2 |
ubiquitin specific peptidase 2 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in increased expression of USP2 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711
|
|
G |
VNN1 |
vanin 1 |
multiple interactions |
ISO |
[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of VNN1 mRNA |
CTD |
PMID:33549593 |
|
NCBI chr 6:132,680,849...132,714,055
Ensembl chr 6:132,680,849...132,714,055
|
|
|
G |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
multiple interactions |
EXP |
[glutathionylcobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form |
CTD |
PMID:26989453 |
|
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
|
|
|
G |
GUCY1A1 |
guanylate cyclase 1 soluble subunit alpha 1 |
multiple interactions |
EXP |
Hydroxocobalamin results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:22171090 |
|
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
|
|
G |
GUCY1B1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions |
EXP |
Hydroxocobalamin results in increased activity of [GUCY1A1 protein binds to GUCY1B1 protein] |
CTD |
PMID:22171090 |
|
NCBI chr 4:155,759,021...155,807,811
Ensembl chr 4:155,758,992...155,807,811
|
|
G |
MMACHC |
metabolism of cobalamin associated C |
affects binding |
EXP |
Hydroxocobalamin binds to MMACHC protein |
CTD |
PMID:19700356 |
|
NCBI chr 1:45,500,300...45,513,382
Ensembl chr 1:45,500,300...45,513,382
|
|
G |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
multiple interactions |
EXP |
[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form; Aluminum inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Arsenic inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Glutathione inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione promotes the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Lead inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; mecobalamin inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Mercury inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form] |
CTD |
PMID:26989453 |
|
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
|
|
|
G |
CAPN1 |
calpain 1 |
multiple interactions |
ISO |
mecobalamin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CAPN1 protein] |
CTD |
PMID:33739591 |
|
NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein] |
CTD |
PMID:21237187 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions |
EXP |
mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP7 protein] |
CTD |
PMID:21237187 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
mecobalamin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFNG protein] |
CTD |
PMID:33739591 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
MBP |
myelin basic protein |
multiple interactions |
ISO |
mecobalamin inhibits the reaction [Thioacetamide results in decreased expression of MBP mRNA]; mecobalamin inhibits the reaction [Thioacetamide results in decreased expression of MBP protein] |
CTD |
PMID:38511258 |
|
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
mecobalamin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of MMP2 protein] |
CTD |
PMID:33739591 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
multiple interactions increases activity |
EXP |
Aluminum inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]; Arsenic inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]; Buthionine Sulfoximine inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]; Lead inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]; mecobalamin inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Mercury inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form] |
CTD |
PMID:26989453 |
|
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
|
|